PROMEDIGEN
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.
PROMEDIGEN
Social Links:
Industry:
Biotechnology Neuroscience
Founded:
2019-01-01
Address:
Daejeon, Taejon-jikhalsi, South Korea
Country:
South Korea
Website Url:
http://www.promedigen.com
Total Employee:
11+
Status:
Active
Contact:
+82 42 867 9113
Email Addresses:
[email protected]
Similar Organizations
Atalanta Therapeutics
Atalanta Therapeutics is a biotechnology company pioneering new treatment options for neurodegenerative diseases.
GenieUs
GenieUs is a bio-research company that uses the human genome to help neurodegenerative diseases.
Minovia
Minovia is a biotechnology research company focusing on treatment for mitochondrial disease.
Mitosense
Mitosense is a biotechnology company operating in stealth mode.
Neurome
Neurome, Inc. is a discovery stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases.
ProCore
ProCore is a biotechnology company developing solutions to improve the quality of life of patients suffering from joint and bone diseases.
Senescence Life Sciences
Senescence Life Sciences is a biotechnology company dedicated to redefining and optimizing brain health and performance.
UniXell
UniXell develops cell therapies for the treatment of cancer and neurodegenerative disorders.
Investors List
Company K Partners
Company K Partners investment in Venture Round - Promedigen
Official Site Inspections
http://www.promedigen.com
- Host name: dot-k1-154.dothome.co.kr
- IP address: 112.175.184.154
- Location: Seongnam-si South Korea
- Latitude: 37.4388
- Longitude: 127.1396
- Timezone: Asia/Seoul
- Postal: 13332
More informations about "Promedigen"
PROMEDIGEN
PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. Proteins control the metabolism, growth, and cell division …See details»
Promedigen - Crunchbase Company Profile & Funding
Promedigen is funded by Company K Partners. When was the last funding round for Promedigen? Promedigen closed its last funding round on Jan 1, 2021 …See details»
ProMedigen - 2025 Company Profile, Funding & Competitors
Jun 22, 2025 ProMedigen is a funded company based in Yuseong District (South Korea), founded in 2019. It operates as a Developer of an anticancer drug candidate. The company …See details»
Promedigen 2025 Company Profile: Valuation, Funding
Information on valuation, funding, cap tables, investors, and executives for Promedigen. Use the PitchBook Platform to explore the full profile.See details»
Promedigen, Inc. - Drug pipelines, Patents, Clinical trials - Synapse
May 7, 2025 Explore Promedigen, Inc. with its drug pipeline, therapeutic area, technology platform, , Disease Domain:Neoplasms, Technology Platform:Small molecule drug, Drug:PMG …See details»
Promedigen - Products, Competitors, Financials, Employees, …
Promedigen is a biotechnology company involved in the treatment of cancer and neurodegenerative disorders. The company has developed a technology platform for the site …See details»
Promedigen - VentureRadar
"PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. PROMEDIGEN has developed a unique, proprietary technology …See details»
PROMEDIGEN INC. (2025) | Korean Company Credit Report
Company Name : PROMEDIGEN INC. , CEO : Park,Hui Seong , Address : 113-dong, 115-ho, 272-16, Munji-ro Yuseong-gu Daejeon, Industry : Research and Experimental ...See details»
Promedigen Inc. Company Profile - Dun & Bradstreet
Promedigen Inc. Company Profile | Daejeon, Daejeon, Republic Of Korea | Competitors, Financials & Contacts - Dun & BradstreetHOME / BUSINESS DIRECTORY / …See details»
프로메디젠 주식회사 - PROMEDIGEN
PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. Proteins control the metabolism, growth, and cell division …See details»
Promedigen - Profiles & Contacts - Crunchbase
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
What is Promedigen and what does the company focus on?
Answer 1. Promedigen is a biotechnology company specializing in treating cancer and neurodegenerative disorders. [1] 2. They have a drug platform focusing on customized cancer …See details»
Promedigen | VentureRadar
PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. PROMEDIGEN has developed a unique, proprietary technology …See details»
PROMEDIGEN Introduction video - YouTube
Jul 24, 2022 PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.Visit our website and learn about PR...See details»
프로메디젠 주식회사 - PROMEDIGEN
PROMEDIGEN is a first-in-class biotechnology company focusing on the treatment of cancer and neurodegenerative disorders. Proteins control the metabolism, growth, and cell division …See details»
Promedigen - Funding, Financials, Valuation & Investors
Jan 1, 2021 Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
Promedigen - Tech Details - Crunchbase
Promedigen is a biotechnology company focusing on the treatment of cancer and neurodegenerative disorders.See details»
프로메디젠 주식회사 - PROMEDIGEN
State-Of-The-Art Medicinal Chemistry and Drug Discovery Engine Rapid DMTA cycles: Initial in vitro data available five days after compound arrival from CRO Team Organization – …See details»
프로메디젠 주식회사 - PROMEDIGEN
However, PROMEDIGEN's technology enables targeting any disease-associated PPI. Proteins are expressed and purified from bacterial culture, and PTMs are site-specifically introduced.See details»
프로메디젠 주식회사 - PROMEDIGEN
프로메디젠 주식회사 - PROMEDIGEN ... 설명See details»